Arlena Davis
Family · Humble, TXNPI 1447771126
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,345, more than ten times the $14 reported in 2019.
Across 118 payments — averaging $22.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$645
- Lundbeck LLC$451
- AbbVie$423
- Collegium Pharmaceutical, Inc.$190
- Corium, LLC$174
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$167
- plus $652 from 15 others
What the payments were for
- Food & beverage$2,702100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $645 |
| Lundbeck LLC | 21 | $451 |
| AbbVie | 20 | $423 |
| Collegium Pharmaceutical, Inc. | 5 | $190 |
| Corium, LLC | 9 | $174 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $114 |
| Sunovion Pharmaceuticals Inc. | 4 | $95 |
| Supernus Pharmaceuticals, Inc. | 2 | $81 |
| Tris Pharma Inc | 3 | $71 |
| Neurocrine Biosciences, Inc. | 3 | $71 |
| Johnson & Johnson | 3 | $41 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Neos Therapeutics, LP | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,702 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diazepam | 18 | $70 |
| Bupropion XlBupropion Hcl | 14 | $46 |
| Lorazepam | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other family in Humble
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.